569 related articles for article (PubMed ID: 35140725)
1. Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe.
Niu Y; Chen J; Qiao Y
Front Immunol; 2022; 13():836223. PubMed ID: 35140725
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation in the tumor microenvironment.
Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L
J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
[TBL] [Abstract][Full Text] [Related]
4. Regulation of epigenetic modifications in the head and neck tumour microenvironment.
Liu H; Wang D; Yang Z; Li S; Wu H; Xiang J; Kan S; Hao M; Liu W
Front Immunol; 2022; 13():1050982. PubMed ID: 36405713
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs: As Critical Regulators of Tumor- Associated Macrophages.
Chatterjee B; Saha P; Bose S; Shukla D; Chatterjee N; Kumar S; Tripathi PP; Srivastava AK
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992449
[TBL] [Abstract][Full Text] [Related]
6. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression.
Saleh R; Toor SM; Sasidharan Nair V; Elkord E
Front Immunol; 2020; 11():1469. PubMed ID: 32760400
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics in cancer: targeting chromatin modifications.
Ellis L; Atadja PW; Johnstone RW
Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
[TBL] [Abstract][Full Text] [Related]
8. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages.
Chen D; Zhang X; Li Z; Zhu B
Theranostics; 2021; 11(3):1016-1030. PubMed ID: 33391518
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?
Tajaldini M; Saeedi M; Amiriani T; Amiriani AH; Sedighi S; Mohammad Zadeh F; Dehghan M; Jahanshahi M; Zanjan Ghandian M; Khalili P; Poorkhani AH; Alizadeh AM; Khori V
Eur J Pharmacol; 2022 Aug; 928():175087. PubMed ID: 35679891
[TBL] [Abstract][Full Text] [Related]
10. Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment.
Zhang J; Huang L; Ge G; Hu K
Adv Sci (Weinh); 2023 Mar; 10(7):e2206169. PubMed ID: 36599655
[TBL] [Abstract][Full Text] [Related]
11. Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery.
Jiang J; Mei J; Yi S; Feng C; Ma Y; Liu Y; Liu Y; Chen C
Adv Drug Deliv Rev; 2022 Jan; 180():114046. PubMed ID: 34767863
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inhibitors and their role in cancer therapy.
Abdelaziz N; Therachiyil L; Sadida HQ; Ali AM; Khan OS; Singh M; Khan AQ; Akil ASA; Bhat AA; Uddin S
Int Rev Cell Mol Biol; 2023; 380():211-251. PubMed ID: 37657859
[TBL] [Abstract][Full Text] [Related]
13. The evolving landscape of N
Gu Y; Wu X; Zhang J; Fang Y; Pan Y; Shu Y; Ma P
Mol Ther; 2021 May; 29(5):1703-1715. PubMed ID: 33839323
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation landscape of tumor-associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple-negative breast cancer patients.
Hey J; Halperin C; Hartmann M; Mayer S; Schönung M; Lipka DB; Scherz-Shouval R; Plass C
Int J Cancer; 2023 Mar; 152(6):1226-1242. PubMed ID: 36408934
[TBL] [Abstract][Full Text] [Related]
15. The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.
Dallavalasa S; Beeraka NM; Basavaraju CG; Tulimilli SV; Sadhu SP; Rajesh K; Aliev G; Madhunapantula SV
Curr Med Chem; 2021; 28(39):8203-8236. PubMed ID: 34303328
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers.
Yen CY; Huang HW; Shu CW; Hou MF; Yuan SS; Wang HR; Chang YT; Farooqi AA; Tang JY; Chang HW
Cancer Lett; 2016 Apr; 373(2):185-92. PubMed ID: 26808576
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic control of the tumor microenvironment.
Marks DL; Olson RL; Fernandez-Zapico ME
Epigenomics; 2016 Dec; 8(12):1671-1687. PubMed ID: 27700179
[TBL] [Abstract][Full Text] [Related]
18. Impact of epigenetic reprogramming on antitumor immune responses in glioma.
McClellan BL; Haase S; Nunez FJ; Alghamri MS; Dabaja AA; Lowenstein PR; Castro MG
J Clin Invest; 2023 Jan; 133(2):. PubMed ID: 36647827
[TBL] [Abstract][Full Text] [Related]
19. Exosomes: A Potential Therapeutic Tool Targeting Communications between Tumor Cells and Macrophages.
Guo W; Li Y; Pang W; Shen H
Mol Ther; 2020 Sep; 28(9):1953-1964. PubMed ID: 32563274
[TBL] [Abstract][Full Text] [Related]
20. Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy.
Tao H; Zhong X; Zeng A; Song L
Front Immunol; 2023; 14():1208870. PubMed ID: 37564659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
